192 related articles for article (PubMed ID: 17923756)
1. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.
Choi EJ; Whang YM; Kim SJ; Kim HJ; Kim YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S52-60. PubMed ID: 17923756
[TBL] [Abstract][Full Text] [Related]
2. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
[TBL] [Abstract][Full Text] [Related]
3. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
4. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
[TBL] [Abstract][Full Text] [Related]
5. Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.
Veal GJ; Errington J; Redfern CP; Pearson AD; Boddy AV
Biochem Pharmacol; 2002 Jan; 63(2):207-15. PubMed ID: 11841795
[TBL] [Abstract][Full Text] [Related]
6. Regulation of RAR beta expression by RAR- and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction.
Li Y; Dawson MI; Agadir A; Lee MO; Jong L; Hobbs PD; Zhang XK
Int J Cancer; 1998 Jan; 75(1):88-95. PubMed ID: 9426695
[TBL] [Abstract][Full Text] [Related]
7. Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers.
Idres N; Marill J; Flexor MA; Chabot GG
J Biol Chem; 2002 Aug; 277(35):31491-8. PubMed ID: 12070176
[TBL] [Abstract][Full Text] [Related]
8. The expression of retinoic acid receptors and the effects in vitro by retinoids in human pancreatic cancer cell lines.
Albrechtsson E; Ohlsson B; Axelson J
Pancreas; 2002 Jul; 25(1):49-56. PubMed ID: 12131771
[TBL] [Abstract][Full Text] [Related]
9. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
10. Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells.
Um SJ; Sin HS; Han HS; Kwon YJ; Kim EJ; Park SH; Kim SY; Bae TS; Park JS; Rho YS
Biol Pharm Bull; 2003 Oct; 26(10):1412-7. PubMed ID: 14519946
[TBL] [Abstract][Full Text] [Related]
11. Ectopic p21sdi1 gene transfer induces retinoic acid receptor beta expression and sensitizes human cancer cells to retinoid treatment.
Teraishi F; Kadowaki Y; Tango Y; Kawashima T; Umeoka T; Kagawa S; Tanaka N; Fujiwara T
Int J Cancer; 2003 Mar; 103(6):833-9. PubMed ID: 12516107
[TBL] [Abstract][Full Text] [Related]
12. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma.
Reynolds CP
Curr Oncol Rep; 2000 Nov; 2(6):511-8. PubMed ID: 11122886
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells.
Um SJ; Lee SY; Kim EJ; Han HS; Koh YM; Hong KJ; Sin HS; Park JS
Cancer Lett; 2001 Dec; 174(2):127-34. PubMed ID: 11689287
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
15. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
[TBL] [Abstract][Full Text] [Related]
16. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
Lehmann S; Paul C; Törmä H
Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
18. The effect of 9-cis-retinoic acid on proliferation and differentiation of a spermatogonia and retinoid receptor gene expression in the vitamin A-deficient mouse testis.
Gaemers IC; Sonneveld E; van Pelt AM; Schrans BH; Themmen AP; van der Saag PT; de Rooij DG
Endocrinology; 1998 Oct; 139(10):4269-76. PubMed ID: 9751509
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
van der Leede BM; van den Brink CE; van der Saag PT
Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
[TBL] [Abstract][Full Text] [Related]
20. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis.
Chapman JS; Weiss KL; Curley RW; Highland MA; Clagett-Dame M
Arch Biochem Biophys; 2003 Nov; 419(2):234-43. PubMed ID: 14592467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
